JPRN-UMIN000050631
Recruiting
N/A
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion) - Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy
ConditionsSuspected prostate cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Suspected prostate cancer
- Sponsor
- Tokai University
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who disagreed with the informed consent Patients who are deemed inappropriate by the principal investigator or subinvestigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Active, Not Recruiting
Phase 1
on-invasive detection of prostate cancer using functional MRI in patients with histopathologically confirmed prostate cancer before prostatectomy - Functional MRI in Prostate CancerEUCTR2009-009476-12-DECharité Campus Mitte, Instituts für Radiologie50
Active, Not Recruiting
Phase 1
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-001387-28-NLRadboud University Medical Center75
Completed
Phase 2
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathologyNL-OMON49534Radboud Universitair Medisch Centrum75
Completed
N/A
Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique.benign prostate hypertrophiaprostate carcinoma10038364NL-OMON37430Atrium Medisch Centrum150